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Introduction
CRISPR-Cas is an adaptive RNA-mediated immune system 
discovered in the bacteria1 and soon after also reported in the 
archaea.2 The primary nucleic acid components of the system are 
the CRISPR, clustered short palindromic repeats regularly inter-
spaced by non-redundant sequences (referred to as spacers)3,4 that 
often derive from fragments (termed protospacers) of infecting 
DNA.5-7 Cas are proteins functionally linked to CRISPR and the 
encoding cas genes are usually arranged in operons located in 
close proximity to repeat-spacer arrays.4 For a recent review of the 
CRISPR-Cas systems, see refs. 8–10.
Three CRISPR-Cas types (I, II and III), each including sev-
eral subtypes, are defined by the presence of signature cas genes.11 
This work deals with the CRISPR-Cas subtype I-E of diverse 
E. coli strains. This system consists of up to three CRISPR-spacer 
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arrays (i.e., CRISPR2.1, CRISPR2.2 and CRISPR2.3)12 made 
of type 2 repeats.13 Next to CRISPR2.1 and CRISPR2.3 arrays 
there is an AT-rich sequence known as the leader,4 here named 
leader2.1 and 2.3, respectively, which contains the promoter that 
directs transcription of the adjoining array.14-16 Two main repeat 
variants, hereinafter named CRISPR-A and CRISPR-T, are found 
across the species, differing by the presence of adenine or thy-
mine, respectively, at the position next to the leader-proximal end 
of the repeat (see Fig. S1) and matching the consensus sequence 
5'-CGGTTTATCC CCGCTGACGC GGGGAACWC-3' (W 
= A or T). Albeit, this is the repeated sequence of the CRISPR 
arrays, it has been recently proposed17 and almost simultaneously 
demonstrated18,19 that the cytosine nucleotide at the leader-distal 
end (Fig. S1) is inserted along with the protospacer, being part 
of the spacer. After this evidence, we will refer to the CRISPR 
duplicon in line with Goren et al.19 as the 28 nt repeated sequence 
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had to be used. Both approaches carry intrinsic concerns. In the 
former, high protein concentration may affect cell fitness and/or 
produce aberrant behavior. In the latter approach, only spacers 
capable of providing efficient interference are detected. In order 
to circumvent these constrains, we implemented a reporter sys-
tem capable of revealing acquisition even at very low CRISPR-
Cas expression and independent of the immune phenotype. 
Using this tool, we have verified previous results obtained with 
the K12 I-E system and also extended them to E. coli strains with 
an alternative variant of cas-E genes, expanding conclusions to 
the species. Interestingly, instead of CTT triplet exhibited by 
the K12 system, the protospacer-associated motif recognized for 
spacer acquisition (named SAM for spacer acquisition motif)30 
by strains carrying the non-K12 cas-E variant is CWT, in agree-
ment with the bioinformatically predicted PAM. Furthermore, 
the implication of the leader on spacer’s orientation was revealed. 
A marked preference for, or exclusion of particular replicons as 
spacer donors, was evidenced. Finally, we hypothesize on the so-
far-enigmatic mechanism of spacer insertion.
Results
CRISPR-spacer integration reporter plasmids. With the aim 
of setting up a strategy for investigating spacer integration by 
the CRISPR-Cas I-E system of E. coli, we developed an assay 
based on positive selection of clones that become resistant to 
chloramphenicol upon expansion of a CRISPR array within 
recombinant plasmids (pCSIR-A and pCSIR-T; see Fig. 1). 
Both plasmids carry an insertion cassette made of a two-repeat 
CRISPR2 array followed by a fragment of the associated leader 
(proximal 43 and 69 bp in pCSIR-A and pCSIR-T, respectively; 
see Fig. 1A). Thus, the -10 TATA box required for transcription 
of the array14,15 is present in pCSIR-T but absent in pCSIR-A. 
Repeats and leader in pCSIR-A belong to variant A (CRISPR-A 
and leader-A, respectively), while pCSIR-T carries T variants of 
both elements (CRISPR-T and leader-T). The CRISPR-spacer-
CRISPR-leader cassette is translationally fused to the beginning 
of lacZ-α (lacZ-α’) and to an out-of-frame (+2 from the lacZ-α 
start codon) gene (cat) for the chloramphenicol acetyltransferase 
(or CAT) protein (Fig. 1A). Translation initiated at the AUG 
codon of lacZ-α stops at the leader. Similarly, in case of deletion 
due to recombination between the two CRISPR units, transla-
tion would stop at another triplet of the leader (see Fig. 1B). In 
order to prevent CAT translation due to duplication (rather than 
new insertion) of a spacer-CRISPR unit, the carried spacer con-
tains an out-of-frame stop tri-nucleotide that would become in 
frame in the duplicated spacer (Fig. 1C).
Insertion experiments were performed with several E. coli 
strains carrying different combinations of pCSIR and cas-con-
taining plasmids. In order to avoid the possibility of perverted 
acquisition due to gross overexpression of cas genes (IPTG-
inducible T7-lac promoters are located upstream of the cas oper-
ons and the lacI gene encoding the lac repressor is included in 
the constructions; see Fig. 2), all assays were performed in the 
absence of IPTG. Hence, at most low levels of cas expression are 
expected (e.g., in case of promoter leakage).
5'-GGTTTATCCC CGCTGACGCG GGGAACWC-3'. Thus, 
duplicons are interspaced by 33–34 nt spacers, 33 nt being the 
most frequently observed (about 95%).12,20-22 Remarkably, the 
leader associated with CRISPR2.1 arrays that are composed 
mainly of CRISPR-A duplicons (hereinafter referred to as leader-
A) differs from the one linked to CRISPR-T-enriched arrays (here 
named leader-T).23 Eight genes, altogether referred to as cas-E, 
constitute the typical cas repertoire of the CRISPR-Cas I-E sys-
tems: cas1, cas2, cas3, cse1, cse2, cas7, cas5 and cas6e,11,24 the last 
five encoding the proteins that make CRISPR-associated com-
plex for antiviral defense or Cascade.25 Immunity is achieved by 
Cas3-catalyzed endonucleotidic cleavage of DNA targeted by the 
spacer sequence in mono-spacer CRISPR RNA (crRNA) mol-
ecules generated by Cascade.14,25-28 The efficiency of interference 
is influenced by the sequence adjoining one end of the proto-
spacer.17,18,28 Connected to this, the consensus protospacer adja-
cent motif (PAM) CWT (5'-protospacerC-WT-3'; see Fig. S1) 
has been defined by the alignment of putative protospacers of this 
CRISPR-Cas system23 and efficient interference is observed when 
this motif is present; notwithstanding that alternative sequences 
in the PAM region, defined as target interference motifs or 
TIMs,29,30 also uphold CRISPR immunity.17,18,25,28
Insertion of new spacers within a CRISPR array (a process 
known as acquisition or adaptation; for a specific review, see ref. 
31) may occur during infection by plasmids or viruses, here-
inafter immunizing the host (therefore referred to as adapted 
cell) against invaders carrying a spacer-matching protospacer 
sequence.17,18,32 Spacer addition is accompanied by a repeat 
duplication, so that spacers remain flanked by CRISPR dupli-
cons. The leader-CRISPR boundary has been shown to be the 
preferential,33-38 albeit not exclusive,39-42 insertion site for several 
CRISPR systems. Although knowledge on the acquisition pro-
cess is limited, recent contributions on the CRISPR-Cas I-E sys-
tem of E. coli K12 have granted substantial advance. Notably, 
evidences have been provided supporting that (1) Cas1 and 
Cas2 are the only Cas proteins required for spacer uptake,32 (2) 
the new repeat generated during spacer integration is a replica 
of the preexisting CRISPR adjoining the leader,32 (3) a single 
repeat is sufficient to elicit adaptation,32 (4) most protospacers 
are selected among sequences next to the tri-nucleotide CTT,17,18 
(5) the leader sequence is directly involved in the expansion of 
the adjacent CRISPR array, independently of its transcription,32 
(6) resident spacers promote addition of new spacers matching 
the target molecule (this activity is termed primed acquisition 
and requires all Cas proteins)18 and (7) the DNA strand targeted 
during interference is selected for subsequent protospacer uptake 
in primed acquisition.17
It is worth mentioning that Cascade genes, together with 
cas1 and cas2, form an operon whose expression is repressed 
under normal laboratory growth by the transcriptional regula-
tor H-NS, at least in E. coli K12.14-16,43 In consequence, neither 
interference nor adaptation by this system has been observed 
in the non-manipulated wild-type strain.14,17,18,25,28,32 Indeed, in 
order to detect acquisition, overproduction of at least Cas1 and 
Cas2 proteins17,18,32 and/or the selection of CRISPR-Cas-induced 
cells showing interference provided by the integrated spacer17,18 
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instead of pCas1-2(K), nine adapted clones were isolated after 
12 h (one growth cycle) incubation (Table S1). These combined 
results indicate that cas genes are transcribed in the two con-
structs despite the absence of induction, and although they also 
suggest that Cascade might facilitate acquisition mediated by 
Cas1 and Cas2, further investigation is required to substantiate 
this implication.
The identity of the spacer acquisition motif (SAM) depends 
on the CRISPR-Cas I-E variant. In a previous comparative 
analysis of leader vs. PAMs of 15 putative CRISPR2 protospacers 
of E. coli,23 a preference for either CAT or CTT was proposed 
for CRISPR arrays associated with leader-A or -T, respectively. 
Now we have confirmed this bias by a similar in silico study per-
formed with 76 putative protospacers showing over 90% identity 
to CRISPR2 spacers of ECOR strains44 and sequenced E. coli 
After the observation that elevated expression of cas1 and 
cas2 genes produces acquisition in the absence of Cascade and 
Cas3,18,32 initial insertion assays were performed with strain 
BL21-AI carrying pCSIR-T and plasmid pCas1-2(K) (contain-
ing cas1 and cas2 genes of K12). BL21-derivative strains lack 
resident cas genes,12 and although BL21-AI harbors a T7 RNA 
polymerase gene under the control of an arabinose-inducible 
promoter, arabinose was not added to the growth medium. 
Under these conditions, one adapted clone (spacer sequence 
AAATACACAG ACACGGAGAA TCACTATGTT TAC; 
identical to a chromosomal sequence adjacent to CTT) was 
obtained after multiple trials and prolonged cultivation (six 
growth cycles, see Materials and Methods). However, when 
plasmid pWUR399 [same vector as pCas1-2(K) but carrying 
Cascade genes transcriptionally fused to cas1-cas2] was used 
Figure 1. schematic representation of the integration reporter cassettes cloned in the pcsIR plasmids and strategy used for specific detection of 
integration events. (A) Integration cassette in pcsIR-A or pcsIR-T consists of a leader and two cRIspR duplicons (cR) interspaced by a spacer (sp-1) 
fused upstream to a fragment of lacZ-α gene (lacZα’) and, downstream, to the complete coding sequence of an out-of-frame cat gene (cat +2). The 
ribosome-binding site (rbs) and the translation initiation codon of lacZ-α (white arrowhead) are indicated. Translation of transcripts generated from 
the lac promoter (plac, denoted with an arrow) will stop at the leader (black arrowhead). A T7 promoter (pT7) is located downstream of cat gene, promot-
ing transcription in the opposite direction (arrow pointing toward the direction of transcription). The sequences of fragments in the leader-cat region 
of pcsIR-T and pcsIR-A with the size of the typical T and A variants respectively of the leader are shown; nucleotides matching the corresponding 
leader variant are shadowed and stop codons as well as, when present, the -10 box underlined and accordingly labeled (initiation site is indicated with 
an arrow pointing toward the direction of transcription). In order to avoid stop codons, thymine was replaced with cytosine at position 42 and with 
adenine at position 70 of the leader in pcsIR-T (see primer TLR in Table S7). Translation of the transcript generated from plac will end at the leader in 
case of deletion (cat would remain out of frame, cat +1) (B), at the duplicated spacer (sp-1) in case of cRIspR-spacer duplication (C) or at the end of the 
in frame cat coding sequence in case of new spacer (sp-2) insertion (D).
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spacer integration assays with natural combinations of the respec-
tive elements in strains harboring equivalent CRISPR-Cas sys-
tems (this way interactions between CRISPR-Cas elements of 
different variants were prevented). First, insertion was assessed in 
K12 carrying an integration reporter plasmid with leader-T and 
CRISPR-T (pCSIR-T), and a second recombinant plasmid with 
either cas1 (pCas1K), cas2 (pCas2K) or cas1 and cas2 [pCas1-
2(K)] of this strain. Efficient spacer integration (59 insertions) 
was observed with pCas1-2(K) (Table S2) within 12 h of incu-
bation, but not with pCas1K or pCas2K after six growth cycles, 
proving that both cas genes are required in a multicopy plasmid 
in order to detect acquisition in K12 with our system. Moreover, 
the analysis of putative precursors of the new spacers showed 
that pCSIR-T plasmids tended to acquire spacers from sequences 
flanking the triplet CTT (42 out of 59 insertions; note that CAT 
was not detected; Table S2). This preference obtained further 
support from the experiments described in the previous section 
performed in BL21-AI carrying pCSIR-T and pWUR399: six out 
of nine insertions had the motif CTT and no CAT was observed 
(see Fig. 3C; Table S1).
genomes (Fig. S2): 11 out of 21 protospacers associated with 
leader-T showed the PAM CTT vs. 1 CAT (Fig. S2), holding 
the CTT PAM sequence (Fig. 3A), and 34 out of 55 predicted 
protospacers associated with leader-A flanked a CAT sequence 
whereas nine showed the triplet CTT (Fig. S2), confirming the 
CWT PAM consensus (Fig. 3B).
Although a connection between PAM and leader is apparent, 
suggesting that the latter might take part in the recognition of 
the specific motif during spacer uptake, additional elements of 
the CRISPR-Cas system could also be involved. As shown in 
Figure S3, in CRISPR2.1 arrays of E. coli, type A repeats co-
occur with leader-A, and CRISPR-T with leader-T. Moreover, in 
a separate study (unpublished data), we noticed that each leader 
type correlates to a specific variant of cas-E genes, differentiating 
two groups within the species defined by the variant that here we 
call cas-EK (after K12 strain), linked to CRISPR/leader of type 
T, and the variant cas-EO (after O157:H7) associated with type 
A, respectively.
In order to experimentally identify the actual SAM sequence 
recognized by each CRISPR/Leader/Cas variant, we performed 
Figure 2. Distribution in pcas1-2(K) of sequences matching distinct spacers sampled in acquisition assays. spacers are shown as black arrows pointing 
toward the leader as they were inserted in the integration cassette. The origin of replication (cDF ori), the genes encoding the lac operon repressor 
(lacI) and a streptomycin resistance protein (smR) as well as the T7-lac promoter (pT7) leading transcription of K-variant cas1-2 genes (cas1-K and cas2-K) 
are shown.
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the DNA content per cell of cas-harboring plasmids was lower 
than that of integration-reporter plasmids (the four constructs 
have similar size and both pCas1-2 plasmids and pWUR399 have 
a CDF origin of replication; see Fig. S4 and Table S4), seven 
insertions were identical to pCSIR fragments vs. 94 to pCas1-2 
sequences (Tables S2 and S3). Moreover, the frequency of CWT 
tri-nucleotides in the constructs does not justify the observed 
underrepresentation of protospacers in the reporter plasmids 
(CTT is more frequent in pCSIR than in pCas1-2 plasmids and 
CAT incidence is similar for all of them; Table S4). In this con-
text, the akin CTT/CAT ratio in pCas1-2 plasmids (0.93–0.99; 
Table S4) provides further support to the preference for CTT 
acquisition motif by cas-EK and CWT by cas-EO systems. Thus, 
either some replicons are less prone to contribute spacers com-
pared with others or there is a preference for certain molecules as 
spacer donors (see Discussion).
Implication of CRISPR-Cas elements in spacer orientation. 
Spacers within a CRISPR locus tend to be equally oriented with 
respect to the PAM.23 Moreover, this conservation in orienta-
tion applies to the CRISPR-Cas type: spacer ends equivalent to 
the protospacer edges adjacent to the PAM (termed PAMEs) of 
CRISPR-Cas type I are oriented toward the leader.11,23,40,45 This 
implies that acquisition proteins (Cas1 and/or Cas2) together 
with element(s) at the spacer integration region (either the leader 
and/or the adjoining CRISPR sequence) are involved in deter-
mining the direction of insertion.
Remarkably, when acquisition was assayed in strain O157:H7 
carrying pCSIR-A and pCas1-2(O) (containing cas1 and cas2 of 
this strain), in contrast with K12, both CTT and CAT proto-
spacer motifs were revealed (detected for 26 and 11, respectively, 
out of 45 insertions; see Fig. 3D; Table S3).
Hence, our data demonstrate that CTT is the dominant SAM 
(CAT was not detected) recognized by the CRISPR-Cas sub-
type I-E of K12 but CTT and CAT by the Cas-EO proteins of 
O157:H7, concurring with the PAMs revealed by the alignment 
of putative precursors of spacers found in CRISPR2 arrays of the 
species (compare Fig. 3A with Fig. 3C and Fig. 3B with Fig. 3D, 
respectively). These results disclose that both system variants may 
differ mechanistically, at least at the CRISPR expansion stage.
Spacer donor molecules. Albeit the content of DNA per 
cell (see Fig. S4) and CTT tri-nucleotide per Kb (Table S4) 
is higher for pCSIR-T than for pWUR399, all nine spacers 
acquired in BL21-AI cells harboring both plasmids were iden-
tical to sequences present in pWUR399 and absent in pCSIR-
T (Table S1). Similarly, although chromosomal DNA is much 
more abundant than pWUR399 sequences (Fig. S4), none of 
these spacers matched a chromosomal fragment (Table S1).
As well as with BL21-AI, experiments performed with K12 
or O157:H7 strains revealed a preference for plasmids carrying 
cas genes as source of spacers. A ratio of 39/104 insertedx spacers 
were identical to chromosomal sequences, just four of them not 
present in pCas1-2 plasmids (Tables S2 and S3). Also, although 
Figure 3. WebLogos generated by the alignment of protospacer regions of E. coli cRIspR2 spacers. sequences containing protospacers (positions -1 
to -33) and the adjoining two nucleotides (positions 0 and 1) of the pAM region were equally oriented with respect to the corresponding spacer in the 
cRIspR array (3' end toward the leader) and aligned in stacks. Logos were obtained for sequences in non-cRIspR loci showing over 90% identity to 
spacers detected in E. coli genomes, associated with leader-T (A) or leader-A (B), as well as for protospacers matching spacers sampled in acquisition 
experiments performed in strains harboring cas-eK (C) or cas-eO (D) encoding genes.
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that, whereas there is flexibility in terms of recognition of the 
leader by Cas proteins to produce acquisition, spacer orienta-
tion requires specific interaction between a given variant of Cas 
protein(s) and the cognate CRISPR/leader. Nevertheless, the 
fact that spacers of resident E. coli CRISPR-Cas I-E systems are 
properly inserted in arrays with distinct leaders (i.e., leader2.1 
and 2.3; see Fig. S3),12,17,18 indicates that sequence variability 
at the leader is tolerated. According to these results, it might be 
concluded that although Cas1-2K are capable of eliciting spacer 
addition at the alternative CRISPR2/leader2 variant, recogni-
tion is impaired. However, the possibility that the anomalous 
insertions were due to an unbalance, as a consequence of the 
multiple insertion cassettes present in our experimental system, 
cannot be ruled out.
Concurring with the recognition of CTT by the K12 system, 
albeit the integration reporter cassette carried a type A leader, a 
fraction of 15/18 integrated spacers corresponded to protospacers 
with this motif and, moreover, CAT was not observed (Table S5). 
This evidences that Cas proteins rather than the leader are the 
main factor involved in SAM selection.
With the aim of gaining insight on the requirements for 
acquisition and taking into account the above referred cor-
relation between leader2.1 and cas-E variant, spacer insertion 
was investigated in K12 carrying an unconventional CRISPR/
leader/cas combination: pCSIR-A and pCas1-2(K). Spacer addi-
tions were obtained (Table S5), showing that K12 Cas pro-
teins are capable of functioning with the alternative CRISPR/
leader2.1 variant. Strikingly, in contrast to the conventional 
insertions invariably observed with cognate pCSIR and pCas1-2 
combinations, seven out of 18 additions were anomalous: (1) 
three CRISPR-spacer inserts contained spacers (identified in 
Table S5 as spacers 1', 24' and 82) two nucleotides longer, and 
the duplicated CRISPR two nucleotides shorter (see Fig. 4) 
than the usual length, and (2) four new spacers were in the 
reversed orientation with respect to the leader (i.e., the PAME 
was located distal to the leader; see spacers labeled with #R in 
Table S5). These results are indicative of inaccurate functioning 
of the artificial leader-Cas combination used and the occurrence 
of reversed spacers supports an involvement of both Cas and 
CRISPR/leader in spacer orientation. In addition, they suggest 
Figure 4. hypothetical mechanism of spacer insertion. Three main steps are distinguished in the cRIspR-spacer integration process: (1) insertion site 
cleavage, (2) spacer integration and (3) cRIspR duplication. (A) The aberrant insertions (atypical cRIspR-spacer sequences) obtained in acquisition 
assays with pcsIR-A and pcas1-2(K) plasmid can be explained after initial nick (filled triangle; our data do not allow determining on which strand) 
between the second and third position of the leader (italics) and a secondary cut (empty triangle) in the complementary strand at a fixed distance 
(28 nt) toward the adjacent cRIspR duplicon (shadowed positions). After ligation of the incoming 33 bp spacer (indicated as N letters) to free ends of 
the insertion site, gaps are filled by DNA polymerization (bold type) leading to the generation of a 26 bp (2-bp trimmed) cRIspR duplicon and a 35 bp 
intervening sequence, thus maintaining the typical 61 bp cRIspR-spacer periodicity. (B) In the normal insertion process, the first cleavage occurs at the 
cRIspR-leader junction, and the second at the fixed distance of 28 nt (i.e., the spacer-cRIspR junction), leading to the duplication of a complete cRIspR 
unit and holding the 61 bp periodicity. Relevant lengths are indicated.
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consequence, and suggest that the more efficient spacers (perhaps 
those targeting sequences with the CAT motif in the case of the 
cas-EO variant) are subsequently selected during the arms race 
with target-invading DNAs.
In another context, we also verified17-19 that the nucleotide for-
merly considered as the first of the CRISPR (distal with respect 
to the leader) invariably matched the 33rd position of the proto-
spacers, whether the SAM was conserved or not (i.e., C, A, T or 
G were at the first nucleotide of the motif 119, 5, 5 and 3 times 
respectively; see Tables S1–3 and S5). Also, some of these non-
consensus sequences showed either CTT (6) or CAT (1) shifted 
one position with respect to the SAM location (Tables S1–3 and 
S5), most likely as a result of inaccurate protospacer cleavage after 
recognition of the motif.
Yosef et al.32 elegantly demonstrated that the first 40–60 bp 
of the leader associated with the CRISPR2.3 of BL21-AI are 
required for efficient expansion of the associated repeat-spacer 
cassette, suggesting that its transcription is not necessary as this 
fragment does not include promoter.14,15 The detection of inser-
tions within the CRISPR cassette of pCSIR-A, which contains 
just the first 43 bp of a leader2.1 (Fig. 1A), expands the obser-
vation made by Yosef et al. with leader2.3 to the leader2.1 in a 
shorter sequence segment.
Apart from the above discussed results, our developed genetic 
strategy also yielded data supporting rejection/preference for 
certain replicons as spacer-donors and the occurrence of a ruler 
mechanism for insertion-site cleavage during the spacer integra-
tion process. Both aspects are discussed in the following sections.
Spacers are preferentially obtained from plasmids carrying 
cas1 and cas2 genes. Sequences in cas-containing plasmids were 
overrepresented in the protospacers sampled (120/132). The fact 
that the majority of putative chromosomal protospacers also exist 
in these plasmids (43/48), even though shared sequences are less 
than 0.1% of the chromosome, further supports the plasmidic 
origin of these spacers. At first glance, interference guided by new 
spacers targeting the chromosome could explain this rejection. 
However, such activity is not expected in the conditions assayed, 
neither in BL21-AI nor in K12. Indeed, resident cas genes are 
absent in BL21-derivative strains and the cas-containing plasmids 
used lack Cas3 protein required for target cleavage. Furthermore, 
H-NS repression of CRISPR arrays and resident cas genes in wild-
type K12 impedes interference,14-16,25 and only cas1 and cas2 have 
been cloned in the assays performed with this strain. In addi-
tion, the association of the CWT protospacer motif, capable of 
eliciting interference,17,18,28 with chromosomal sequences match-
ing new spacers (34/48), also argues against the occurrence of 
CRISPR-mediated degradation activity. Once interference is dis-
carded, the apparent rejection of the chromosome as spacer donor 
observed here, and also by Yosef et al.32 could be explained by its 
disruption during protospacer excision.
A different reason must account for the underrepresentation 
of spacers from integration reporters vs. cas-containg plasmids 
(7:120) as they are multicopy replicons and, thus, disruption of 
the donor molecule does not imply plasmid loss and besides, anti-
biotics were used during the acquisition assays to select cells main-
taining both plasmids (see Materials and Methods). Likewise, 
As in the assays performed with cognate CRISPR/leader and 
Cas pairs, the majority of new spacers (17/18) matched pCas1-2 
sequences (seven of them were also present in the chromosome), 
and just one was exclusive of the chromosome, while no spacer 
originated from pCSIR-A (Table S5).
Discussion
Utility of integration reporter plasmids. CRISPR-spacer inte-
gration reporter plasmids allow sensitive detection of insertions 
without the requirement of an elevated production of Cas pro-
teins or the selection of adapted cells relying on the interference 
phenotype provided by the new spacer. Yet, compared with the 
native situation, the presence in our system of multiple copies 
of the CRISPR locus may lead to altered behavior. Moreover, 
detectable additions are restricted to sequences leading to the 
synthesis of a functional CAT protein. Thus, 34 nt spacers, 
observed in CRISPR arrays in a proportion of about 4%,12,20-22 
would be excluded as only integration of a 3n+1 bp fragment, 
such as a CRISPR-spacer unit with the canonical length of 61 bp, 
can potentially be selected (Fig. 1D). About 62% of them will 
be detected due to the absence of stop codons in phase with the 
reporter gene (see Materials and Methods). Although multiple 
insertions (3n+1) might be observed, only single additions were 
sampled. This could be explained considering that integrations 
must be sequential; a plasmid carrying multiple new spacers 
would be outnumbered with those harboring a lower number 
(i.e., due to more replication cycles of the latter). The increased 
chance of stop codons (probability of 0.38 for one insertion vs. 
0.85 for four; see Materials and Methods) could also be a reason. 
Taking into account these considerations, solid conclusions on 
the adaptation process can be drawn.
To highlight, the dominant SAM revealed in our assays 
with the K12 CRISPR-Cas system was CTT (73.5%, 64/87, of 
motifs; see Table S6), in agreement with predictions from the 
comparative analysis of protospacer regions and with interfer-
ence-reliant acquisition studies performed under increased lev-
els of Cas proteins.17,18 Conversely, in an interference-unrelated 
analysis with overexpressed cas1 and cas2 genes of K12, as few 
as 36 out of 94 protospacers (38.3%) adjoined CTT,32 perhaps 
as a consequence of the elevated Cas1 and Cas2 levels utilized. 
Strikingly, as from the analysis of data reported by Datsenko et 
al.18 and Swarts et al.,17 we observed that CAT motif was appar-
ently excluded (not sampled in assays with cas-EK; Table S6). 
The reason for this omission is intriguing, notably since efficient 
interference against targeted protospacers flanking CAT has been 
reported.28,46 Otherwise, in contrast to the K12 system and con-
current with in silico predictions, we have identified the CWT 
SAM triplet for the CRISPR-Cas I-E system of E. coli O157:H7, 
revealing mechanistic differences among variants of a CRISPR-
Cas subtype within a given species. Yet, CAT tri-nucleotide is 
the most frequent PAM observed for spacers present in leader-
A-associated CRISPR arrays, but CTT is preferentially selected 
by Cas-EO proteins. Then, our combined bioinformatic and 
experimental results demonstrate that specific SAMs are required 
for protospacer recognition independent of their interference 
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61 bp inserts but not of 58 or 64 bp supports the ruler mechanism 
hypothesis. Hence, taking into account these considerations, 
we can conclude that the initial step of integration consists of 
sequential cleavages at the insertion sites. The first cut, at the 
CRISPR/leader boundary, is sequence-dependent (probably rec-
ognized by either Cas1 or Cas2).51,52 The second nick takes place 
at the leader-distal end of the CRISPR and is independent of 
the CRISPR sequence, most likely determined by the distance 
from the previous cleavage (Fig. 4B). Apart from Cas1 and Cas2, 
acquisition must require non-Cas proteins with activities like 
DNA ligation and polymerization. This could be achieved by the 
implication of DNA repair mechanisms, providing a new mean-
ing to the interactions of Cas1 with key components of repair 
systems, including RecB, RecC and RuvB.51 Although we have 
considered insertion of a double-stranded spacer sequence, inte-
gration of a single strand from the protospacer and its subsequent 
replication cannot be dismissed.
A ruler mechanism has also been proposed for protospacer 
excision by another CRISPR-Cas type I system.42 As a conse-
quence of this common strategy directing the two stages of the 
acquisition process (i.e., protospacer excision and spacer integra-
tion), CRISPR-spacer periodicity is conserved.
Materials and Methods
Strains. E. coli K12 str. MG1655, E. coli O157:H7 str. EDL931 
(Colección Española de Cultivos Tipo, CECT 4267) and E. coli 
str. BL21-AI (Novagen) were used as hosts in integration assays. 
The three strains harbor CRISPR2.2 and CRISPR2.3-leader2.3 
loci. K12 strains also carry a CRISPR2.1 array made of CRISPR-T 
duplicons associated with a leader of type T and a complete set of 
cas-EK genes. The CRISPR2.1 locus of E. coli O157:H7 is made 
of type A repeats and leader, and adjoins a complete set of cas-
EO genes. The CRISPR2.1 locus of BL21-derivative strains con-
sists of CRISPR-A duplicons and both leader and cas genes are 
absent.12 An arabinose-inducible T7 RNA polymerase is encoded 
in BL21-AI, whereas homologous genes are not present in the 
genome of the other two strains.
The CRISPR2.1 locus of E. coli str. ECOR69,53 used as tem-
plate for PCR amplification of the integration-reporter cassette 
cloned in pCSIR-A, has CRISPRs and leader of type A.12
Plasmids. Plasmids developed in this study and details of 
their construction are indicated in Table S4 and the respective 
primers used are shown in Table S7. The 9 Kb pWUR339 plas-
mid (provided by John van der Oost’s laboratory) derives from 
the low-copy number pCDF-1b vector (Novagen) and carries 
the Cascade-cas1-cas2 operon of E. coli K12 under a T7-lac pro-
moter.25 Constructions were performed by cloning DNA frag-
ments (Fig. S5) obtained by PCR amplification with primers 
containing or not (cloning in 3'-T overhangs) restriction sites (see 
Tables S4 and S7).
The pCR2.1-Cm plasmid was obtained by cloning the 
chloramphenicol acetyltransferase (cat) gene from pKK232-
854 in the high-copy number (pUC origin) pCR2.1 vector 
(Invitrogen). pCSIR-A derived from pCR2.1-Cm by insertion 
of a sequence carrying 43 bp of the leader2.1 and the adjacent 
the involvement of primed acquisition17,18 as a way to favor inte-
gration from molecules targeted by a preexisting spacer can be 
dissmissed as cas-containing plasmids lack sequences similar to 
chromosomal or pCSIR spacers (the only sequences matching 
pre-existing spacers are in the chromosomal and pCSIR CRISPR 
arrays, where interference is anticipated to be prevented).47,48
As a tentative explanation, we propose that the presence of 
cas genes involved in acquisition in the prefered spacer-donor 
replicon could account for a more efficient uptake of sequences 
close to their coding regions, through transcription-translation 
coupling.49 This possibility is substantiated by the detection of 
spacers in CRISPR arrays, as well as RNAs in ribonucleopro-
tein Cascade complexes, which sequences match regions in 
close proximity to CRISPR-Cas loci, including cas genes.12,25,50 
Alternatively, CRISPR-harboring molecules (including the 
chromosome) could be less prone to contribute spacers as con-
sequence of an unforeseen discerning mechanism. This matter 
requires further investigation.
The large set of spacers acquired from pCas1-2(K) sequences 
allowed us to assess whether a preference for particular regions 
was apparent. Protospacers were scattered along the plasmid 
and located on both strands in coding and intergenic regions 
(Fig. 2), corroborating previous reports that dismiss an influence 
of transcription or the direction of replication on protospacer 
selection.17,18,32
Proposal of a ruler mechanism for insertion-site cleavage. 
When an unconventional CRISPR/leader/cas combination was 
used (i.e., CRISPR-A/leader-A/cas-EK), we observed anomalous 
insertions (four events of reversed spacer orientation and three 
atypical CRISPR-spacer sequences; see Table S5), most probably 
due to wrong leader/Cas interactions. Strikingly, the three atypi-
cal sequences shared the same odd features: (1) the di-nucleotide 
GG at the spacer-adjacent end of the duplicated CRISPR was 
missing (Fig. 4) and (2) CRISPR intervening sequences were 
35 bp long (instead of 33) containing AC at the leader-distal 
end (Fig. 4), independently of the sequence at the correspond-
ing positions in the putative protospacer (see Table S5). These 
observations fit with integration between the second and third 
nucleotide of the leader (A
1
C
2
-T
3
) instead of at the CRISPR-
leader junction (C-A
1
; Figs. 1A and 4A). Accordingly, note that 
the CRISPR-leader boundary in CRISPR2.1 arrays associated 
with cas-EK genes is CT (see Figs. 4A; Fig. S5). As a consequence 
of the erroneous insertion, the leader-proximal end of the distal 
CRISPR will adjoin the extra di-nucleotide AC (Fig. 4A). The 
fact that the new CRISPR is trimmed at the spacer-adjacent end 
suggests that following an initial cleavage at the leader, the new 
duplicon was generated after a subsequent nick within the adja-
cent CRISPR at a fixed distance (28 nt from the first cut) unre-
lated to a putative recognition of the CRISPR end sequence (gain 
of AC by the leader-distal duplicon is compensated with GG 
loss by the proximal CRISPR; see Fig. 4A). Yet, as insertion of a 
63 bp CRISPR-spacer unit in the pCSIR plasmids would not be 
detected (it would not restore cat frame), a second cleavage at this 
distance from the first nick cannot be dismissed. Nevertheless, 
the three additions observed demonstrate that the leader-distal 
CRISPR edge is dispensable for cleavage, and the occurrence of 
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Transformation procedure. Transformations were per-
formed by electroporation (2.45 KV, 25 μF, 200 Ω) using 
an Electroporator 2510 (Eppendorf). Electrocompetent cells 
were prepared following the procedure described by Shi et al.58 
Transformant colonies were selected on LB agar plates containing 
the appropriate antibiotics.
Spacer acquisition assay. As a preliminary step of the acquisi-
tion assays, in order to confirm sensitivity to chloramphenicol, 
colonies of E. coli carrying integration reporter and cas-con-
taining plasmids were streaked on LB plates supplemented with 
25 μg/ml chloramphenicol (Sigma). For each acquisition assay, a 
different sensitive clone was grown for 12 h at 37°C with shaking 
(150 rpm) in LB liquid medium supplemented with the antibiotic 
necessary for plasmid selection (100 μg/ml ampicillin, Sigma, 
or 20 μg/ml streptomycin, Sigma, for pCSIR and cas-contain-
ing plasmids, respectively). Additional (up to six) 12 h cycles of 
growth were performed (i.e., 1:300 dilutions of the culture in 
fresh medium and incubation under the same conditions), until 
chloramphenicol-resistant colonies (expectedly carrying an extra 
spacer-CRISPR unit) were detected by spreading culture samples 
on solid LB medium containing 25 μg/ml chloramphenicol. In 
order to avoid sampling colonies derived from a single adapted 
cell, only one resistant colony from each assay was selected for 
further analysis. Insertion was primarily assessed by PCR ampli-
fication of the integration cassette with primers T7 and M13R 
matching flanking sequences in the vector (see Table S7). 
Usually, PCR fragments with increased size were observed along 
with non-extended amplicons, the latter likely due to extant 
copies of the original construction. In these cases, in order to 
select cells enriched with the plasmid carrying the insertion, 
three additional cycles of growth (1:5,000 dilutions, incubated 
at 37°C with shaking for 24 h) were performed in LB medium 
supplemented with increasing concentrations of chloramphenicol 
(75 μg/ml, 150 μg/ml and 200 μg/ml). Finally, plasmids were 
extracted and sequenced with M13R primer.
The first growth cycle in which adapted clones were detected 
provides an estimation of the efficiency of acquisition.
Probability of detection of integrated spacers. To calculate 
the probability of integrations not eliciting cat translation due to 
the presence in the spacer of stop codons in phase with the ATG 
start codon in the reporter plasmids, an equivalent frequency of 
the four nucleotides in the donor DNA was considered. Then, 
the probability of stop triplets (TAA, TAG or TGA) is 3 × 1/43 = 
3/64 and of a triplet not being a stop codon 1 - 3/64 = 61/64. For 
each 33 nt spacer inserted there are 10 tri-nucleotides that could 
produce termination. For example, in the case of a single inser-
tion, the remaining three nucleotides would complete triplets in 
the adjoining CRISPR: the nucleotide at the leader-distal end 
of the spacer contributes the triplet TCN and the opposite two 
nucleotides the NCG codon at the edges of the flanking CRISPR 
duplicons (underlined nucleotides). Hence, the probability of n 
insertions without translation interruption is (61/64)10n (i.e., 0.62 
for a single insertion). For a single insertion (n = 1), taking into 
account that only 95% of naturally occurring spacers are 33 nt 
long, the probability of integration detection is (61/64)10 × 0.95 
= 0.59.
CRISPR-spacer-CRISPR from ECOR69 strain. pCSIR-T was 
constructed by cloning in the 3'-T overhangs of the linearized 
pCR® 2.1 vector (TA Cloning® Kit from Invitrogen) a segment 
containing 69 bp of the leader2.1 and the adjacent CRISPR-
spacer-CRISPR amplified from E. coli K12 str. MG1655, and a 
subsequent insertion of an amplicon containing the cat gene as 
in pCR2.1-Cm. pCas1-2(K) and pCas1-2(O) were obtained by 
insertion in the pCDF-1b vector of amplicons containing both 
cas1 and cas2 genes from pWUR399 and E. coli O157:H7 str. 
EDL931, respectively.
For cloning into the 3'-T overhangs of the linearized pCR® 2.1 
vector, PCR products were obtained with recombinant Taq poly-
merase (Invitrogen). DNA amplicons to be cloned in plasmids 
other than linear pCR® 2.1 vector (Table S4) were obtained with 
the Expand High Fidelity PCR System (Roche). A Mastercycler 
Gradient (Eppendorf) thermal cycler was used for PCR incuba-
tions. PCR products were purified and afterwards digested with 
Thermo Scientific enzymes according to Double Digest web 
tool recommendations (www.thermoscientificbio.com/webtools/
doubledigest/). Ligations were performed with T4 DNA Ligase 
(New England Biolabs). Following ligation, pCR2.1 and pCDF-
1b-derived plasmids were transformed in TOP10 (Invitrogen) or 
NovaBlue (Novagen) strains, respectively, and constructions were 
verified by sequencing with primers T7 (pCR2.1 and pCDF-1b) 
and M13R (pCR2.1) or T7t (pCDF-1b).
Detection of CRISPR, leader and PAM sequences. Leaders 
of ECOR strains were determined by sequencing PCR amplifica-
tion products as described by Diez-Villaseñor et al.12 CRISPR 
and leaders in available E. coli genomes were identified with the 
CRISPRFinder program (www.crispr.u-psud.fr/Server/).55
For the identification of E. coli CRISPR2 PAMs associated 
with A or T CRISPR-leader variants, protospacer regions with 
at least 30 nt identity to spacers of CRISPR-Cas I-E systems of 
E. coli strains were searched with the BLASTn program56 run 
against the Nucleotide Collection database (www.blast.ncbi.nlm.
nih.gov/Blast.cgi) and aligned using the leader-proximal end as 
a reference. Similarly, the experimental SAMs were determined 
by the alignment of sequences matching (100% identity) spacers 
acquired in the integration assays and detected in the replicons 
of the corresponding host using BLASTn or Genious R6 created 
by Biomatters Ltd. (available from www.geneious.com/). The 
DNA strands carrying the protospacer nucleotides complemen-
tary to the corresponding spacer sequence in the crRNA were 
aligned using WebLogo (www.weblogo.berkeley.edu/logo.cgi/)57 
to obtain sequence logos as described elsewhere.23
DNA purification and sequencing. Genomic and plasmid 
DNA were purified from cells grown in LB medium (10 g/l 
tryptone, 5 g/l yeast extract and 10 g/l NaCl) using Wizard® 
Genomic DNA Purification Kit (Promega) and High Pure 
Plasmid Isolation Kit (Roche), respectively. PCR products and 
restriction fragments were purified with GFXTM PCR DNA and 
Gel Band Purification Kit (GE Healthcare).
Sequencing was performed with the Big Dye Terminator 
Cycle Sequencing kit in an ABI PRISM 310 DNA Sequencer 
(Applied Biosystems) following the manufacturer’s instructions 
(Servicios Técnicos de Investigación, Universidad de Alicante).
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Perspectives
The robustness of our results and their consistency with bioin-
formatically predicted and other experimentally supported data 
validate the integration reporter plasmids we have developed as a 
powerful and reliable genetic tool for characterizing acquisition 
by the CRISPR-Cas I-E system of E. coli. For instance, the occur-
rence of spacer insertion into these constructions and its efficiency 
under diverse conditions can serve to identify growth parameters 
and additional proteins affecting this process. Furthermore, the 
same approach could be used to develop equivalent strategies and 
instruments applicable to alternative systems and strains.
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